Article
Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System
27 Apr 2023
Abstract excerpt
Numerous clinical studies have revealed the utility of circulating AM (adrenomedullin) or MR-proAM (mid-regional proAM 45-92) as an effective prognostic and diagnostic biomarker for a variety of cardiovascular-related pathophysiologies. Thus, there is strong supporting evidence encouraging the exploration of the AM-CLR (calcitonin receptor-like receptor) signaling pathway as a therapeutic target. This is further...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
